Mirabegron ER 25 mg & Solifenacin succinate 5 mg .. .

MIRAGRON S 
Mirabegron (ER) (25mg) and Solifenacin succinate (5mg)
MIRAGRON S  are two medications used in combination to treat overactive bladder (OAB) in adults. The "ER" in Mirabegron (ER) stands for "extended-release," indicating that it is a long-acting or extended-release formulation of Mirabegron. Here's some information about each of these medications:

Mirabegron (ER) (25mg):

Mirabegron is a medication used to treat overactive bladder (OAB).
The "ER" formulation means that it is an extended-release version of Mirabegron, designed to provide a more continuous release of the medication over time.
Mirabegron works by activating beta-3 adrenergic receptors in the bladder, which relaxes the bladder muscle and increases its capacity to hold urine, reducing the symptoms of OAB.
Solifenacin Succinate (5mg):

Solifenacin is an anticholinergic medication used to treat OAB. It is also known by its brand name, Vesicare.
Solifenacin works by blocking the action of certain neurotransmitters in the bladder, helping to reduce bladder muscle contractions and improve bladder control.
The combination of Mirabegron (ER) and Solifenacin succinate is often prescribed to provide more comprehensive relief of OAB symptoms. By using both medications, patients may experience reduced urgency, frequency, and urinary incontinence associated with OAB.

Here are some key points to consider:

Prescription Requirement: Both Mirabegron (ER) and Solifenacin succinate are prescription medications, and their use should be overseen by a healthcare provider.

Dosage: The dosages of these medications may vary depending on the specific formulation and the patient's response to treatment. The combination product you mentioned contains 25 mg of Mirabegron (ER) and 5 mg of Solifenacin succinate, which is a common combination.

Effectiveness: This combination of medications can be effective in managing OAB symptoms. It provides dual mechanisms of action to control bladder muscle activity and reduce symptoms like urgency and incontinence.

Side Effects: Common side effects of these medications may include dry mouth, constipation, blurred vision, and urinary retention. As with any medication, individual responses to side effects can vary.

Precautions: It's important to discuss your medical history and any other medications you are taking with your healthcare provider to ensure that this combination is safe and appropriate for your specific situation.

If you have been prescribed the combination of MIRAGRON S  for the treatment of overactive bladder, it's crucial to follow your healthcare provider's recommendations regarding the dosage and duration of treatment. They can provide guidance on whether this combination is suitable for your specific condition and address any questions or concerns you may have about the medication. 
 Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
sterisonline.com